You are viewing: South Korea Pen Needles Market analysis
Part of: Pen Needles Market (Global)

The South Korea Pen Needles Market was valued at $4.58 Million in 2024 and projected to reach to $6.85 Million by 2029, representing a compound annual growth rate of 6.9%. South Korea's pen needles market demonstrates stable growth potential supported by its advanced healthcare ecosystem and rising diabetes management needs.

South Korea Pen Needles Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Korea Pen Needles Market Trends and Insights

  • This represents a compound annual growth rate (CAGR) of 6.9% throughout the forecast period.
  • South Korea's advanced healthcare infrastructure and high prevalence of diabetes are driving demand for injectable delivery devices, positioning the country as a significant market within the Asia Pacific region. The pen needles market in South Korea is supported by increasing adoption of insulin pens and GLP-1 receptor agonists among diabetic patients.
  • South Korea's aging population and rising healthcare expenditure contribute to market expansion between 2024 and 2029.
  • Additionally, South Korea's strong pharmaceutical manufacturing base and regulatory framework facilitate product innovation and market penetration by both domestic and international manufacturers..

Key Market Statistics

  • CAGR (2024-2029) 6.9% CAGR
  • Market Size, 2024 ~USD 4.58 Million
  • Forecast, 2029 ~USD 6.85 Million
  • Country South Korea

South Korea Pen Needles Market Overview

Steady Market Expansion :

South Korea's pen needles market is projected to grow from $4.58 million in 2024 to $6.85 million by 2029, representing a consistent 6.9% CAGR driven by increasing diabetes prevalence and healthcare modernization.

Advanced Healthcare Infrastructure :

South Korea's sophisticated medical system and high healthcare spending per capita support widespread adoption of injectable delivery devices, positioning the country as a mature market for pen needle solutions.

Rising Diabetes Burden :

Growing diabetes incidence in South Korea is a primary market driver, with an aging population and lifestyle changes increasing demand for convenient and effective insulin delivery mechanisms among patients.

Below-Global Growth Rate :

At 6.9% CAGR, South Korea's market growth trails the global average of 9.2%, indicating a more saturated market with established competition and slower adoption acceleration compared to emerging regions.

South Korea Pen Needles Market Dynamics

  • The country's strong pharmaceutical distribution network and high patient compliance with injectable therapies create a favorable environment for market expansion.
  • Healthcare providers and manufacturers benefit from established reimbursement frameworks and regulatory clarity. Looking ahead, South Korea's market will likely be shaped by technological innovations in needle design, increasing patient preference for user-friendly devices, and potential market consolidation among suppliers.
  • While growth remains below global rates, the market's maturity and stability offer reliable opportunities for established players seeking sustainable revenue streams in the Asia-Pacific region..

Market Ecosystem

logo-mobile

PEN NEEDLES MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Develops a wide range of pen needles designed for insulin and GLP-1 delivery, including safety-engineered and ultra-fine variants compatible with multiple pen systems. Ensures precise dosage, minimizes needlestick injuries, and enhances patient comfort and adherence in diabetes management.
company logo
Manufactures high-quality pen needles optimized for its insulin pens and GLP-1 therapies, focusing on smooth penetration and ease of use. Improves injection comfort, ensures consistent insulin delivery, and promotes better self-management among diabetic patients.
company logo
Offers pen needles under the “Omnican” brand, designed for accurate insulin injection with ergonomic grip and minimal penetration force. Provides enhanced safety, precision, and comfort, reducing anxiety associated with daily injections.
company logo
Specializes in pen needles compatible with various injection pens and integrates user-friendly, low-pain technology for chronic disease management. Enhances user experience through ergonomic design, reliable connectivity with injection devices, and improved compliance.
company logo
Produces fine-gauge pen needles featuring advanced Japanese micro-needle technology for accurate and gentle drug delivery. Reduces injection pain, improves dosing precision, and supports patient confidence in self-injection therapy.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Drug Delivery Devices

Top Technologies
  • Disposable Autoinjectors
  • Reusable Autoinjectors
  • Insulin Pumps
  • Pen Injectors
  • Transdermal Patches
Top Companies
  • Novo nordisk a/s
  • Becton, Dickinson and Company
  • Terumo Corporation
  • Medtronic plc
  • Nipro Corporation

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • South Korea's pen needles market is valued at $4.58 million in 2024 and is forecast to grow to $6.85 million by 2029.
      • South Korea demonstrates a 6.9% CAGR, reflecting steady demand driven by diabetes prevalence and injectable therapy adoption.
      • South Korea's advanced healthcare system and aging demographics support sustained market growth through 2029.
      • South Korea's regulatory environment and manufacturing capabilities attract both local and international market participants.

      Pen Needles Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment SAFETY PEN NEEDLES (Type)
      Forecast Period 2024–2029
      Growth Rate CAGR of 9.2% from 2024 to 2029
      Largest Segment STANDARD PEN NEEDLES (Type)
      Market Size Base Year (Billions) ~USD 1.82 (2024)
      Revenue Forecast (Billions) ~USD 3.08 (2029)
      Segments Covered Type, Length, Application, Mode Of Purchase, Care Setting

      South Korea Pen Needles Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Type

      • Safety Pen Needles
      • Standard Pen Needles

      By Length

      • 10Mm
      • 12Mm
      • 4Mm
      • 5Mm
      • 6Mm
      • 8Mm

      By Application

      • Glp-1 Therapy
      • Growth Hormone Therapy
      • Insulin Therapy
      • Osteoporosis
      • Other Applications

      By Mode Of Purchase

      • Online Purchase
      • Otc Purchase
      • Other Modes Of Purchase
      • Prescription-Based Purchase

      By Care Setting

      • Home Care Settings
      • Hospitals & Clinics
      • Hospitals And Clinics
      • Other End Users

      Target Audience

      • Medical Device Manufacturers : Manufacturers need South Korea-specific market data to assess market entry viability, competitive positioning, and growth potential for pen needle product lines in this advanced healthcare market.
      • Healthcare Distributors & Suppliers : Distributors require detailed market insights to optimize inventory management, negotiate supplier contracts, and identify high-growth opportunities within South Korea's established pharmaceutical supply chain.
      • Pharmaceutical Companies : Pharma firms need South Korea market intelligence to align insulin and GLP-1 drug launches with appropriate delivery device strategies and understand patient adoption patterns in this mature market.
      • Healthcare Investors & Analysts : Investment professionals require South Korea-specific valuation data, growth forecasts, and competitive analysis to make informed decisions on healthcare sector investments and portfolio allocation.
      • Hospital & Clinic Administrators : Healthcare facility leaders need market data to evaluate procurement strategies, budget planning for diabetes management programs, and understand emerging device technologies relevant to South Korean patients.

      Key Companies in the South Korea Pen Needles Market

      CompanyHQOwnershipStrongest segments
      KINDRED HEALTHCARE INC.United StatesPrivate CompanyInjectable and infusion-based delivery in LTAC hospitals,Oral drug administration in inpatient rehabilitation facilities,Contract rehabilitation and outpatient-related drug administration support,
      ATS AUTOMATION TOOLING SYSTEMS INCCanadaPublic CompanyTurnkey automated manufacturing and assembly systems,Lifecycle services and digital/connected factory solutions,Contract manufacturing and value-added integration,
      ALLERGAN PLCIrelandPrivate CompanyMedical Aesthetics & Dermatology,Eye Care,Neuroscience & CNS,
      CONSORT MEDICALUnited KingdomPrivate CompanyInhalation delivery devices,Injectable and autoinjector devices,Nasal and other specialty devices,
      HENRY SCHEINUnited StatesPublic CompanyGlobal Distribution & Value-Added Services,Global Specialty Products,Global Technology,
      EMBECTA CORP.United StatesPublic CompanyPen needles,Syringes,Safety injection devices,
      NOVO NORDISK A/SDenmarkPublic CompanyGLP-1 for Diabetes (injectable and oral),Obesity Care (GLP-1, including Wegovy pill),Insulin and Smart Pens (NovoPen 6, Echo Plus, needles),
      YPSOMEDSwitzerlandPublic CompanyPen injectors,Auto-injectors,Wearable injectors and patch pumps,
      TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
      NIPROJapanPublic CompanyDialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products,Pharmaceutical-related (generics, kits, CDMO for injectables and oral drugs),
      ARKRAY, INC.JapanPrivate CompanyDiabetes testing & blood glucose monitoring,Urinalysis,Immunodiagnostics,
      HTL-STREFAPolandPrivate CompanySafety lancets for professional capillary sampling,Personal lancets for home blood glucose monitoring,Pen needles for diabetes therapy,
      BERPU MEDICAL TECHNOLOGY CO., LTD.ChinaPrivate CompanyRegular insulin pen needles,Safety insulin pen needles and pens,Hypodermic and hypo-dermal needles,

      KINDRED HEALTHCARE INC.

      Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates with 64,200 employees. The company provides healthcare services and related solutions across the United States.

      ATS AUTOMATION TOOLING SYSTEMS INC

      ATS Automation Tooling Systems Inc. is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.

      ALLERGAN PLC

      Allergan PLC is an Ireland-based private company founded in 1983 with 17,400 employees. The company operates in the pharmaceutical and medical aesthetics sectors.

      CONSORT MEDICAL

      Consort Medical is a United Kingdom-based private company founded in 1938 with 2,000 employees. The company provides medical device and pharmaceutical delivery solutions.

      HENRY SCHEIN

      Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. The company is a distributor of healthcare products and services to medical, dental, and veterinary professionals.

      EMBECTA CORP.

      Embecta Corp. is a United States-based public company founded in 1924 with 1,850 employees. The company manufactures and distributes diabetes care and medical devices.

      NOVO NORDISK A/S

      Novo Nordisk A/S is a Denmark-based public company founded in 1923 with 67,900 employees. The company is a global pharmaceutical company specializing in diabetes, obesity, and other chronic diseases.

      YPSOMED

      Ypsomed is a Switzerland-based public company founded in 1984 with 2,025 employees. The company develops and manufactures injection and infusion systems for diabetes and other therapeutic areas.

      TERUMO CORPORATION

      Terumo Corporation is a Japan-based public company founded in 1921 with 30,591 employees. The company manufactures and distributes medical devices, blood products, and pharmaceutical solutions globally.

      NIPRO

      Nipro is a Japan-based public company founded in 1947 with 38,593 employees. The company manufactures and supplies medical devices, pharmaceuticals, and healthcare products worldwide.

      ARKRAY, INC.

      Arkray, Inc. is a Japan-based private company founded in 1960 with 566 employees. The company manufactures diagnostic and medical devices for healthcare applications.

      HTL-STREFA

      HTL-Strefa is a Poland-based private company founded in 2000. The company manufactures medical devices and related healthcare products.

      BERPU MEDICAL TECHNOLOGY CO., LTD.

      Berpu Medical Technology Co., Ltd. is a China-based private company founded in 2000. The company manufactures medical devices and related healthcare solutions.

      Reasons to Buy this Report

      • Market-Specific Sizing & Forecasts : Access precise valuation data for South Korea's pen needles market with detailed 2024-2029 projections, enabling accurate budget allocation and revenue forecasting for regional operations.
      • Competitive Landscape Intelligence : Understand South Korea's mature market dynamics, identify key competitors, and assess market saturation levels to develop differentiated strategies in this established healthcare segment.
      • Regulatory & Reimbursement Insights : Gain clarity on South Korea's healthcare reimbursement frameworks, regulatory requirements, and compliance pathways specific to pen needle products for faster market entry and commercialization.
      • Patient & Provider Behavior Analysis : Leverage South Korea-specific data on diabetes prevalence, patient preferences for injectable devices, and healthcare provider adoption patterns to optimize product positioning and marketing strategies.
      • Strategic Growth Opportunities : Identify untapped segments within South Korea's market, assess expansion potential in aging demographics, and benchmark performance against regional competitors for sustainable business growth.

      Frequently asked questions

      What is the current size of South Korea's pen needles market?

      South Korea's pen needles market was valued at $4.58 million in 2024 and is expected to reach $6.85 million by 2029.

      What is the projected growth rate for pen needles in South Korea?

      South Korea's pen needles market is projected to grow at a CAGR of 6.9% from 2024 to 2029.

      What factors are driving growth in South Korea's pen needles market?

      South Korea's market growth is driven by increasing diabetes prevalence, rising adoption of insulin pens, an aging population, and expanding healthcare expenditure.

      How does South Korea's market compare to the global pen needles market?

      South Korea's 6.9% CAGR is lower than the global CAGR of 9.2%, reflecting a more mature but stable market with consistent demand.

      What is the forecast market size for South Korea's pen needles market in 2029?

      South Korea's pen needles market is forecast to reach $6.85 million by 2029, representing growth of $2.27 million from 2024.

      RESEARCH METHODOLOGY

      This research study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

      Secondary Research

      This research study involved the wide use of secondary sources such as directories, databases such as D&B Hoovers, Bloomberg Businessweek, and Factiva; white papers; and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the pen needles market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various supply-side and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the pen needles market. Primary sources from the demand side included personnel from hospitals and clinics, researchers, lab technicians, purchase managers, and stakeholders from corporate & government bodies.

      A breakdown of the primary respondents for the pen needles market (supply side) market is provided below:

      Pen Needles Market
 Size, and Share

      Note 1: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
      Note 2: C-level executives include CEOs, COOs, CTOs, and VPs.
      Note 3: Other primaries include sales managers, marketing managers, and product managers.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The market size for pen needles was determined using data from four different sources, which will be discussed below. Each method was evaluated, and a weighted average was calculated based on the number of assumptions made by each approach. The market size for pen needles was ultimately derived from these three distinct sources, as detailed in the following sections.

      Pen Needles Market: Bottom-up Approach & Top-down Approach

      Pen Needles Market Top Down and Bottom Up Approach

      Data Triangulation

      The entire market was divided into five segments to determine its size. Data triangulation and market breakdown processes were applied where necessary to complete the market engineering process and accurately arrive at the statistics for each segment.

      To estimate the market size and forecast growth, secondary data from both paid and unpaid sources were utilized. A thorough analysis of the sales of pen needles from major players helped establish their market rankings. Due to data limitations, the revenue share for certain companies was calculated based on an in-depth examination of their product portfolios and individual sales performance. This information was verified at each stage through detailed interviews with industry professionals.

      Market Definition

      A pen needle is a hollow needle fixed within a plastic hub and connected to injectable pens. These pen needles come in various lengths and diameters, making them suitable for use by both healthcare professionals and patients to administer injectable medications. They are electro-polished to ensure smooth, thin, and fine-point tips, which enhance comfort and ease during penetration. Pen needles offer a modern alternative for drug delivery compared to traditional injection methods.

      Key Stakeholders

      • Manufacturers of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
      • Original equipment manufacturing companies
      • Suppliers and distributors of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
      • Healthcare service providers
      • Teaching hospitals and academic medical centers
      • Health insurance players
      • Government bodies/municipal corporations
      • Regulatory bodies
      • Business research and consulting service providers
      • Authorities framing reimbursement policies for pen needles
      • Venture capitalists
      • Market research and consulting firms

      Report Objectives

      • To define, describe, and forecast the pen needles market based on type, length, application, mode of purchase, setting, and region.
      • To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, challenges, and opportunities)
      • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall pen needles market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the pen needles market in North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC Countries
      • To profile the key players and comprehensively analyze their market shares and core competencies in the pen needles market
      • To track and analyze competitive developments such as partnerships, expansions, acquisitions, collaborations, product launches, agreements, and other developments in the pen needles market
      • To benchmark players within the pen needles market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings.

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

      Company Information

      • Detailed analysis and profiling of additional market players (up to 5)

      Geographic Analysis

      • Further breakdown of the Rest of Europe pen needles market into Denmark and Norway, among others
      • Further breakdown of the Rest of Asia Pacific pen needles market into countries such as Vietnam

       

      Get the Full Pen Needles Market Report

      Full forecast, segment splits, and company analysis for all Pen Needles Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status